Axomadol

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameAxomadol
Drug Alias Name阿索马多AxomadolumAxomadol hydrochlorideGRT-0151YEN-3324 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsChronic PainLow Back PainAcute Pain +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGrunenthal Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrünenthal GmbHEndo International Plc
Active IndicationsN/A
Inactive IndicationsChronic PainLow Back PainAcute Pain +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG